StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SP $1. 00 again?

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Oct 17, 2021 12:14pm

157 Views

Post# 34015093

RE:RE:SP $1. 00 again?

There is an upcoming meeting on December 9 and vote is based on shareholders of record as of this Friday October 22.

What are they seeking shareholder approval on
-a share consolidation,
-additional board members,
-to release more shares to Care once the milestone is reached
-something else

Let's see what interest it brings by Friday.

frewil11 wrote: They have to show through financials a significant growing number of Aristotle testing quarter over quarter , or a large signing of a health group of some kind ( the elusive Golden goose ) I will get back in only if I see this happening and I don't care one bit of paying for shares trading alot higher than this .

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing